Research Paper Volume 13, Issue 2 pp 1929—1946

A TP53-based immune prognostic model for muscle-invasive bladder cancer

class="figure-viewer-img"

Figure 2. Prognosis of IPM in TCGA MIBC cohort and meta-GEO MIBC cohort. (A, D) Kaplan-Meier survival analysis in TCGA cohort and meta-GEO cohort, OS in low risk subgroup was higher than those in the high risk subgroup. (B, E) Risk assessment in TCGA cohort and meta-GEO cohort, the correlation between the risk score (upper) and the expression of four immune-associated genes (bottom). (C, F) Time-dependent ROC curves of IPM.